Opaleye Management Inc.

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$887.7M2026 Q3
Positions58
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.62.6%

Opaleye Management Inc. reported 58 positions worth $887.7M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ETON (14.2%). Biggest move: exit APOGEE THERAPEUTICS INC ($51.8M).

10 / 58 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ETONEton Pharmaceuticals$125.6M14.15%2,440,000——+24.1%
▸ 2 IRONDisc Medicine$71.7M8.07%1,095,000——+17.0%
▸ 3 HROWHarrow$64.8M7.30%2,105,000——-2.2%
▸ 4 LQDALiquidia$63.8M7.19%2,110,000——+89.7%
▸ 5 URGNUroGen Pharma$58.5M6.59%1,439,996——-30.8%
▸ 6 SLGLSol-Gel Technologies$41.2M4.64%555,000——-25.8%
▸ 7 MGTXMeiraGTx$39.6M4.46%3,600,000——-16.5%
▸ 8 TGTXTG Therapeutics$31.1M3.50%557,000——+15.7%
▸ 9 ACOGAlpha Cognition$29.7M3.35%3,303,904——-13.0%
▸ 10 IMMXImmix Biopharma$29.4M3.31%2,825,000———

Pro Feature

The remaining 48 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Opaleye Management Inc. hold as of Q3 2026?

Opaleye Management Inc. reported 58 positions worth $887.7M in its Q3 2026 13F filing. Largest positions: ETON (14.2%), IRON (8.1%), HROW (7.3%), LQDA (7.2%) and URGN (6.6%).

What did Opaleye Management Inc. buy in Q3 2026?

New positions: SMMT, HRMY, GRCE, SNDX and GOSSAMER BIO INC (10 in all). Added to: IRON, BHVN, VSTM, IMMX and CBIO (17 in all).

What did Opaleye Management Inc. sell in Q3 2026?

Reduced: ETON, MBX, EWTX, LQDA and RZLT (19 in all). Sold out entirely: APOGEE THERAPEUTICS INC, XOMAGBP, NTLA, PHAT and COAG (10 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.